Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
The Medicines and Healthcare products Regulatory Agency (MHRA) is a pivotal entity in the pharmaceutical preparation manufacturing industry, headquartered in Great Britain. Established in 2003, the MHRA plays a crucial role in ensuring the safety, efficacy, and quality of medicines and healthcare products across the UK.
With a focus on regulatory oversight, the agency is responsible for the approval and monitoring of pharmaceuticals, medical devices, and blood products. Its unique position allows it to facilitate innovation while safeguarding public health. The MHRA has achieved significant milestones, including the rapid approval of COVID-19 vaccines, underscoring its commitment to timely access to essential healthcare solutions. As a leader in regulatory science, the MHRA continues to enhance its market position through robust frameworks and collaborative initiatives within the healthcare sector.
-19 vs industry average
Medicines and Healthcare products Regulatory Agency’s score of 21 is lower than 34% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing has typical carbon intensity
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Medicines and Healthcare products Regulatory Agency yet.
The Medicines and Healthcare products Regulatory Agency (MHRA), headquartered in Great Britain and operating within the Pharmaceutical Preparation Manufacturing industry, reported a total of approximately 9.35 billion kg CO2e in emissions for the 2015 and 2016 financial years. This figure, sourced from their 2015-2016 Annual Report, represents greenhouse gas emissions across three scopes. Specific breakdowns for Scope 1, Scope 2, or Scope 3 emissions are not detailed in the provided data.
The MHRA has not publicly disclosed specific carbon reduction targets or commitments, nor are there any SBTi (Science Based Targets initiative) approved targets or participation in climate initiatives like the Climate Pledge. Further details regarding their current climate strategy and emissions performance beyond the 2015-2016 reporting period are not available in the provided information.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Medicines and Healthcare products Regulatory Agency yet.
No scope 3 category breakdown has been disclosed yet.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more